An Open-label Pharmacokinetic Study of TS-172 in Patients on Hemodialysis

NCT06849778 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Patients on Hemodialysis

Interventions

DRUG: TS-172

Sponsor

Taisho Pharmaceutical Co., Ltd.